Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Lrg participates in lipopolysaccharide preconditioning-induced brain ischemia injury via TLR4 signaling pathway.

Gong G, Bai S, Wu W, Hu L, Liu Y, Niu J, Dai X, Yin L, Wang X.

J Mol Neurosci. 2014 Sep;54(1):20-6. doi: 10.1007/s12031-014-0240-8. Epub 2014 Feb 15.

PMID:
24526448
2.

LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury.

Vartanian KB, Stevens SL, Marsh BJ, Williams-Karnesky R, Lessov NS, Stenzel-Poore MP.

J Neuroinflammation. 2011 Oct 14;8:140. doi: 10.1186/1742-2094-8-140.

3.

Hepatic preconditioning using lipopolysaccharide: association with specific negative regulators of the Toll-like receptor 4 signaling pathway.

Sano T, Izuishi K, Hossain MA, Inoue T, Kakinoki K, Hagiike M, Okano K, Masaki T, Suzuki Y.

Transplantation. 2011 May 27;91(10):1082-9. doi: 10.1097/TP.0b013e31821457cb.

PMID:
21403587
4.

Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3.

Marsh B, Stevens SL, Packard AE, Gopalan B, Hunter B, Leung PY, Harrington CA, Stenzel-Poore MP.

J Neurosci. 2009 Aug 5;29(31):9839-49. doi: 10.1523/JNEUROSCI.2496-09.2009.

5.

IRAK-4 kinase activity-dependent and -independent regulation of lipopolysaccharide-inducible genes.

Koziczak-Holbro M, Glück A, Tschopp C, Mathison JC, Gram H.

Eur J Immunol. 2008 Mar;38(3):788-96. doi: 10.1002/eji.200737886.

6.

Abnormal expression of Toll-like receptor 4 is associated with susceptibility to ethanol-induced gastric mucosal injury in mice.

Ye HH, Hua R, Yu L, Wu KJ, Fei SJ, Qin X, Song Y, Cao JL, Zhang YM.

Dig Dis Sci. 2013 Oct;58(10):2826-39. doi: 10.1007/s10620-013-2727-5. Epub 2013 Jun 7.

PMID:
23744365
7.

Astrocytic Toll-like receptor 3 is associated with ischemic preconditioning-induced protection against brain ischemia in rodents.

Pan LN, Zhu W, Li Y, Xu XL, Guo LJ, Lu Q, Wang J.

PLoS One. 2014 Jun 10;9(6):e99526. doi: 10.1371/journal.pone.0099526. eCollection 2014.

8.

Participation of MCP-induced protein 1 in lipopolysaccharide preconditioning-induced ischemic stroke tolerance by regulating the expression of proinflammatory cytokines.

Liang J, Wang J, Saad Y, Warble L, Becerra E, Kolattukudy PE.

J Neuroinflammation. 2011 Dec 24;8:182. doi: 10.1186/1742-2094-8-182.

9.

Baicalin inhibits TLR2/4 signaling pathway in rat brain following permanent cerebral ischemia.

Tu XK, Yang WZ, Shi SS, Chen Y, Wang CH, Chen CM, Chen Z.

Inflammation. 2011 Oct;34(5):463-70. doi: 10.1007/s10753-010-9254-8.

PMID:
20859668
10.

C-reactive protein triggers inflammatory responses partly via TLR4/IRF3/NF-κB signaling pathway in rat vascular smooth muscle cells.

Liu N, Liu JT, Ji YY, Lu PP.

Life Sci. 2010 Sep 11;87(11-12):367-74. doi: 10.1016/j.lfs.2010.07.012. Epub 2010 Aug 4.

PMID:
20670634
11.

Protective effect of lipopolysaccharide preconditioning in hepatic ischaemia reperfusion injury.

Sano T, Izuishi K, Hossain MA, Kakinoki K, Okano K, Masaki T, Suzuki Y.

HPB (Oxford). 2010 Oct;12(8):538-45. doi: 10.1111/j.1477-2574.2010.00211.x. Epub 2010 Sep 2.

12.

Lipopolysaccharide preconditioning protects hepatocytes from ischemia/reperfusion injury (IRI) through inhibiting ATF4-CHOP pathway in mice.

Rao J, Qin J, Qian X, Lu L, Wang P, Wu Z, Zhai Y, Zhang F, Li G, Wang X.

PLoS One. 2013 Jun 4;8(6):e65568. doi: 10.1371/journal.pone.0065568. Print 2013.

13.

Prothymosin-alpha preconditioning activates TLR4-TRIF signaling to induce protection of ischemic retina.

Halder SK, Matsunaga H, Ishii KJ, Ueda H.

J Neurochem. 2015 Dec;135(6):1161-77. doi: 10.1111/jnc.13356. Epub 2015 Oct 16.

PMID:
26364961
14.

Interleukin-1 receptor associated kinases-1/4 inhibition protects against acute hypoxia/ischemia-induced neuronal injury in vivo and in vitro.

Yang YF, Chen Z, Hu SL, Hu J, Li B, Li JT, Wei LJ, Qian ZM, Lin JK, Feng H, Zhu G.

Neuroscience. 2011 Nov 24;196:25-34. doi: 10.1016/j.neuroscience.2011.08.059. Epub 2011 Sep 10.

PMID:
21925238
15.

Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components.

Dobrovolskaia MA, Medvedev AE, Thomas KE, Cuesta N, Toshchakov V, Ren T, Cody MJ, Michalek SM, Rice NR, Vogel SN.

J Immunol. 2003 Jan 1;170(1):508-19.

16.

Toll-like receptor 9: a new target of ischemic preconditioning in the brain.

Stevens SL, Ciesielski TM, Marsh BJ, Yang T, Homen DS, Boule JL, Lessov NS, Simon RP, Stenzel-Poore MP.

J Cereb Blood Flow Metab. 2008 May;28(5):1040-7. doi: 10.1038/sj.jcbfm.9600606. Epub 2008 Jan 9.

17.
18.

Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke.

Caso JR, Pradillo JM, Hurtado O, Lorenzo P, Moro MA, Lizasoain I.

Circulation. 2007 Mar 27;115(12):1599-608. Epub 2007 Mar 19.

19.

Euscaphic acid isolated from roots of Rosa rugosa inhibits LPS-induced inflammatory responses via TLR4-mediated NF-κB inactivation in RAW 264.7 macrophages.

Kim IT, Ryu S, Shin JS, Choi JH, Park HJ, Lee KT.

J Cell Biochem. 2012 Jun;113(6):1936-46. doi: 10.1002/jcb.24062.

PMID:
22234926
20.

Plasminogen activator inhibitor type-1 deficiency exaggerates LPS-induced acute lung injury through enhancing Toll-like receptor 4 signaling pathway.

Hua F, Ren W, Zhu L.

Blood Coagul Fibrinolysis. 2011 Sep;22(6):480-6. doi: 10.1097/MBC.0b013e328346ef56.

PMID:
21577093
Items per page

Supplemental Content

Write to the Help Desk